Because tirzepatide works through an additional receptor (GIP) that semaglutide doesn't target, some people who respond poorly to semaglutide may respond to tirzepatide's dual mechanism
Generic competition upon patent expiry in 2031 will erode market share and pricing power
As a classic satiation signal, however, the literature illustrates a mixed picture of GIP involvement with an at best weak anorectic response profile being reported for GIP receptor (GIPR) signaling
It may be appropriate when: Skin quality is good There is no scar-related indentation Muscle separation is minimal or absent In patients with a C-section shelf, liposuction alone often fails to correct the contour abnormality and may worsen the appearance if excess skin remains
If you want to learn how to be successful in natural bodybuilding, read the book The tortoise and the hare. The tortoise wins every time
We provide recommendations for use of specific obesity pharmacotherapies with proven benefit in specific subpopulations atherosclerotic cardiovascular disease, heart failure with preserved ejection fraction, metabolic dysfunctionassociated steatohepatitis, prediabetes, type 2 diabetes, obstructive sleep apnea, osteoarthritis and for those with certain specific monogenic causes of obesity